ImmunityBio, Inc. (IBRX)
7.175
+0.26
(+3.68%)
USD |
NASDAQ |
Jun 08, 16:00
7.16
-0.02
(-0.21%)
After-Hours: 20:00
ImmunityBio Market Cap : 7.515B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sana Biotechnology, Inc. | 724.46M |
| Erasca, Inc. | 3.997B |
| Arrowhead Pharmaceuticals, Inc. | 10.38B |
| Denali Therapeutics, Inc. | 3.102B |
| Cogent Biosciences, Inc. | 5.321B |
Market Cap Related Metrics
| PS Ratio | 49.00 |
| PEG Ratio | -0.1825 |
| Price | 7.175 |
| Earnings Yield | -11.90% |
| PEGY Ratio | -0.1825 |